A Season of Reflection and Progress in Wound Management
Summary: December 2025 editorial by John C. Lantis, II, MD, FACS uses the holiday season for reflection on wound care advancements amid uncertainties. Notes stability in tissue/biologic products, shift to online-only journal, surge in international submissions offering diverse insights, upcoming consensus documents on debridement across sites and postoperative dehiscence. Anticipates 18 months of studies on tissue products in DFUs/VLUs, long-term pressure injury outcomes, and atypical wounds. Emphasizes recharging, engaging with content for better patient understanding (medical/psychological/social), and advancing knowledge to reduce suffering, heal wounds, and elevate QoL. Welcomes feedback to enhance article value; highlights Wound Care Collaborative Community contributions (image quality, trial designs, PROs).
Key Highlights:
- Progress: Biologics stability, global research, consensus docs.
- Upcoming: Debridement/dehiscence guidelines; healing trajectory studies.
- Message: Reflect on commitment; focus on patient-centered outcomes.
- Relevance: Year-end overview tying to synthetic/innovative therapies and chronic wound challenges.
Keywords: wound management progress, biologic products, debridement consensus, atypical wounds